Patient anxiety rises at the point where lab results become visible
The shift to immediate patient access to laboratory test results has created a new kind of waiting room, one that exists on a phone screen rather than in a clinic. Patient anxiety now begins before the result is released, continues through the interval when the result is still unseen, and may change again the moment the numbers appear without a clinician’s explanation attached. This survey study in JAMA Network Open examines three closely linked questions: how anxious patients feel while waiting for laboratory results, how that anxiety changes after viewing the results, and whether patients want to keep seeing results immediately in the future.
The topic sits at the intersection of transparency and reassurance. Immediate release policies are designed to give people faster access to information about their own care, yet laboratory values can be clinically ambiguous even when they are not dangerous. A borderline abnormality may be minor, transient, or already expected by the treating clinician, but to a patient reading it alone, the same value can feel alarming. In that setting, the emotional response is not a side issue; it becomes part of the clinical event itself.
The study focus is narrow and practical. Investigators asked patients about anxiety while waiting for results, then again after the results were visible, and finally about their intention to keep viewing future results. Those three endpoints matter because they map onto the full patient experience: anticipation, interpretation, and repeated behavior. A system that accelerates information delivery can only be judged fairly if it also accounts for what that acceleration does to distress and whether patients still want the same access after they have lived through it.
This is where laboratory medicine meets behavioral science. Test results are often treated as neutral data, but they are also emotionally charged signals about disease, progression, response to treatment, and the possibility of new diagnoses. For some patients, seeing the result immediately may reduce uncertainty and prevent prolonged worry. For others, the absence of explanation may amplify fear, especially if the result is abnormal, unexpected, or difficult to interpret without context.
The abstract available from this feed centers on the study aims and endpoints rather than on the detailed numerical findings. Even so, the clinical question is obvious: does immediate release help patients feel informed, or does it leave them stranded with information they cannot yet fully understand? In routine practice, that distinction affects more than satisfaction scores. It influences patient trust, the volume of urgent messages sent after hours, the emotional burden of waiting, and the workflow required for clinicians who must interpret results after patients have already seen them.
A one-sentence reality follows from that design. A lab value delivered early is not always delivered cleanly.
The bedside implications extend well beyond a single test panel. Patients with chronic disease often track repeated laboratory testing over time, and each new result can reinforce either control or uncertainty. When access is immediate, the emotional distance between the blood draw and the patient’s interpretation shrinks to minutes or hours rather than days. For some people that is empowering. For others, it creates a cycle of anticipatory worry every time a specimen is collected.
The study’s final endpoint, intention to view future results, is especially important because it reaches beyond a one-time emotional reaction. A patient who feels anxious during one episode may still value immediate access if it supports autonomy, planning, or shared decision-making. Another may prefer slower release if it allows a clinician to frame the result before the patient reads it. Preferences like these are not abstract; they shape how health systems should communicate test results, how portals are configured, and how clinicians prepare patients before testing.
A second blunt reality follows from that logic. Faster access can either reduce uncertainty or intensify it, depending on what the result means and who sees it first.
The pathophysiology here is emotional rather than biochemical, but the underlying mechanism is familiar in medicine: uncertainty activates stress. Waiting for test results can trigger vigilance, catastrophic thinking, and repeated checking of patient portals. Once the result appears, the emotional response depends on prior expectations, disease burden, and the presence or absence of immediate clinical interpretation. A mildly abnormal result may be benign in physiology and destabilizing in psychology, while a normal result may feel reassuring only if the patient understands why the test was ordered in the first place.
The study therefore addresses a question that health systems cannot avoid for long. If immediate laboratory release is now part of routine care, then patient anxiety before and after viewing results becomes a clinical outcome, not just an inconvenience. The most useful next step is not simply to ask whether patients can see their results faster, but to determine how that access should be paired with communication, context, and follow-up so that transparency does not become a source of avoidable distress.